Form 4 for MIRM Mirum Pharmaceuticals, Inc.
Accepted 2024-07-24 00:00:00 ET · period of report 2024-07-23 · accession 0001415889-24-020053 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-07-24 | 2024-07-23 | MIRM | Peetz Christopher | CEO, Dir | M - OptEx | $2.94 | +34.0K | 126.8K | +37% | +$100.0K |
| D | 2024-07-24 | 2024-07-23 | MIRM | Peetz Christopher | CEO, Dir | M - OptEx | $0.00 | -34.0K | 278.5K | -11% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-23 | M | A | 34,013 | $2.94 | 126,783 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2024-07-23 | M | D | 34,013 | $0.00 | 278,487 | D | $2.94 · — to 2029-03-11 | 34,013 Common Stock | (F1) 1/4th of the shares vested one year after November 5, 2018, and the balance of the shares vested in a series of 36 successive equal monthly installments at the end of each month thereafter. |